Based on the above theoretical calculation results and experimental validation, it can be concluded that (20R)-panaxadiol can regulate CREB phosphorylation through activating β2 receptor and promote the improvement of body thermogenesis and the corresponding mitochondrial biosynthesis, thus achieving the anti-obesity effect. The gene discussed is CREB1; the disease is obesity due to melanocortin 4 receptor deficiency.